Nowreen Haq | Endocrinology and Metabolism | Best Researcher Award

Published on by Global Scholar Awards

Dr.Nowreen Haq | Endocrinology and Metabolism | Best Researcher Award

Asst Program Director at AAMC Medical Center Internal Medicine Residency program and division of endocrinology, metabolism,United States

Dr. Nowreen Haq, MD, MPH, is a highly accomplished physician-researcher with specialized expertise in endocrinology, metabolism, obesity, and preventive medicine. Her leadership as Principal Investigator at the NIH, particularly in machine learning-based clinical research, reflects a deep commitment to advancing evidence-based medicine. Dr. Haq has played key roles in academic institutions such as Johns Hopkins, NYU, and the University of Maryland, where she has influenced clinical education and residency program development. Her contributions to national committees and protocol development highlight her impact on healthcare policy and clinical standards. She has been recognized with multiple grants for quality improvement and patient safety initiatives, demonstrating her ability to translate research into meaningful outcomes. While greater visibility into her publication record could further bolster her profile, Dr. Haq’s multidisciplinary approach, clinical innovation, and dedication to improving patient care make her a strong and deserving candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Nowreen Haq has an extensive and distinguished educational background that spans international and U.S. institutions. She earned her MBBS degree from Dhaka University in Bangladesh in 2001, laying the foundation for her medical career. She then pursued a Master of Public Health (MPH) from the prestigious Johns Hopkins Bloomberg School of Public Health in 2006, where she gained advanced training in public health and preventive medicine. Dr. Haq completed a Transitional Year Residency at Bassett Healthcare, affiliated with Columbia University, in Cooperstown, New York (2007–2008). She then entered a combined Internal Medicine and Preventive Medicine residency program at Griffin Hospital/Yale School of Public Health/Yale School of Medicine, finishing in 2010. Her academic journey reflects a commitment to excellence, integrating clinical medicine with public health. Dr. Haq is board-certified in Internal Medicine, Endocrinology & Metabolism, and Obesity Medicine, demonstrating a multidisciplinary expertise that enhances both her clinical practice and research contributions.

Professional Experience📝

Dr. Nowreen Haq brings over a decade of diverse and impactful professional experience in clinical medicine, academic leadership, and research. She currently serves as a Physician Executive and Endocrinologist at Luminis Healthcare, where she also holds the role of Assistant Program Director for the Internal Medicine Residency Program. At the University of Maryland Midtown Health Systems, she leads a weight loss and metabolic program, integrating evidence-based protocols to improve cardiometabolic outcomes. Previously, she held clinical and leadership roles at institutions such as Chase Brexton Healthcare, Greater Baltimore Medical Center, NYU Langone, and Johns Hopkins Bayview Medical Center. Dr. Haq has been instrumental in protocol development, quality improvement initiatives, and multidisciplinary care model implementation. She is also actively involved with the NIH as a Principal Investigator in research using machine learning for large clinical databases. Her broad experience spans inpatient and outpatient care, research leadership, and academic mentorship, reflecting her dedication to advancing medical excellence.

Research Interest🔎

Dr. Nowreen Haq’s research interests lie at the intersection of endocrinology, obesity, metabolism, and preventive medicine, with a strong emphasis on improving clinical outcomes through evidence-based interventions. She is particularly focused on the use of data-driven approaches, including machine learning, to analyze large clinical trial databases and enhance treatment protocols. As Principal Investigator at the NIH’s NIDDK, she has led innovative research projects aimed at refining care models for metabolic and endocrine disorders. Dr. Haq is also deeply invested in quality improvement and patient safety, having developed and implemented several clinical protocols to reduce complications such as deep vein thrombosis and medication errors. Her work often bridges clinical practice and research, translating findings into actionable strategies that improve patient care across diverse populations. Additionally, her involvement in national committees and academic programs supports her commitment to advancing research that informs both policy and practice in modern healthcare.

Award and Honor🏆

Dr. Nowreen Haq has received multiple awards and honors that reflect her commitment to clinical excellence, research innovation, and quality improvement. She was nominated for a Clinical Excellence Award across all five facilities within the Johns Hopkins Healthcare system, recognizing her outstanding patient care and leadership. Dr. Haq is a two-time recipient of the prestigious Pyramid Small Grant for Patient Safety and Quality Improvement, awarded for her work on enhancing medication safety and preventing deep vein thrombosis in post-discharge patients. She was also honored with a faculty fellowship from the Student Outreach Resource Center for her efforts in community-based medication safety education for elderly patients. Additionally, she received a research grant from the Agency for Healthcare Quality and Research (AHRQ) to study the utilization of cardiac resynchronization therapy in Medicare patients. These accolades underscore her dedication to advancing healthcare through research, education, and patient-centered innovation.

Research Skill🔬

Dr. Nowreen Haq possesses a robust set of research skills that span clinical investigation, data analysis, protocol design, and healthcare quality improvement. As a Principal Investigator at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), she has demonstrated expertise in utilizing machine learning approaches to analyze large-scale clinical trial databases, showcasing her ability to apply advanced analytical tools to real-world healthcare challenges. She is skilled in developing and implementing evidence-based clinical protocols, particularly in endocrinology and metabolic disease management, and has successfully translated research findings into clinical practice improvements. Dr. Haq’s proficiency extends to grant writing, having secured competitive funding for projects focused on patient safety and quality enhancement. Her experience in multidisciplinary collaboration and her role in national medical committees further reflect her strategic research planning and leadership abilities. These skills collectively enable her to lead impactful, patient-centered research initiatives that inform both policy and clinical standards.

Conclusion💡

Dr. Nowreen Haq is exceptionally qualified for the Best Researcher Award, particularly due to her blend of clinical excellence, leadership in protocol development, innovative research using machine learning, and strong academic roles. While her research impact would be better showcased with more visibility into her publication metrics, her contributions to translational medicine, safety improvement, and protocol innovation clearly position her as a top contender.

Publications Top Noted✍

  • Title: Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk
    Authors: M Mongraw-Chaffin, MC Foster, CAM Anderson, GL Burke, N Haq, …
    Year: 2018
    Citations: 436
    Journal: Journal of the American College of Cardiology, 71(17), 1857–1865

  • Title: Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis
    Authors: SG Coca, F Ismail-Beigi, N Haq, HM Krumholz, CR Parikh
    Year: 2012
    Citations: 373
    Journal: Archives of Internal Medicine, 172(10), 761–769

  • Title: Predictors of response to cardiac resynchronization therapy: a systematic review
    Authors: J Rickard, H Michtalik, R Sharma, Z Berger, E Iyoha, AR Green, N Haq, …
    Year: 2016
    Citations: 98
    Journal: International Journal of Cardiology, 225, 345–352

  • Title: Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure
    Authors: HJ Michtalik, HC Yeh, CY Campbell, N Haq, H Park, W Clarke, …
    Year: 2011
    Citations: 82
    Journal: The American Journal of Cardiology, 107(8), 1191–1195

  • Title: Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice
    Authors: LS Lim, N Haq, S Mahmood, L Hoeksema, ACPM Committee
    Year: 2011
    Citations: 81
    Journal: American Journal of Preventive Medicine, 40(3), 381.e1–381.e10

Calver Pang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Jian Han | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Jian Han | Medicine and Dentistry | Best Researcher Award

Orthopedic Surgeon at Department of Orthopaedic Surgery, The First People’s Hospital of Huzhou, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, China

Dr. Jian Han is a distinguished orthopedic surgeon specializing in orthopedic surgery at The First People’s Hospital of Huzhou, China. His research focuses on reverse total shoulder arthroplasty, bone-to-tendon healing, and innovative biomaterials, with numerous high-impact publications in prestigious international journals. His work on 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites has significantly advanced orthopedic treatments. Through extensive collaborations with leading researchers, he has contributed to improving surgical techniques and patient outcomes. His studies on extracorporeal shockwave therapy, bone marrow aspirate concentrate, and tendon healing mechanisms demonstrate his commitment to innovative and clinically relevant research. While his expertise is highly specialized, expanding his interdisciplinary collaborations and leadership roles in academic societies could further enhance his impact. With a strong publication record and dedication to advancing orthopedic medicine, Dr. Han stands out as a leading researcher in his field, making significant contributions to both academia and clinical practice.

Professional Profile 

Education

Dr. Jian Han pursued his medical education and specialized training in orthopedic surgery, establishing a strong foundation in musculoskeletal medicine and surgical techniques. He completed his medical degree and orthopedic residency at prestigious institutions, where he developed expertise in advanced orthopedic procedures, including reverse total shoulder arthroplasty and bone-to-tendon healing. His education emphasized both clinical excellence and research innovation, leading him to actively engage in studies on biomaterials, regenerative medicine, and orthopedic biomechanics. Throughout his academic journey, he collaborated with renowned experts, contributing to groundbreaking research in orthopedic surgery. Dr. Han’s commitment to lifelong learning is evident in his extensive publication record and his continuous efforts to integrate cutting-edge scientific advancements into clinical practice. His educational background has played a crucial role in shaping his expertise, enabling him to make significant contributions to orthopedic research and patient care.

Professional Experience

Dr. Jian Han is an experienced orthopedic surgeon currently serving in the Department of Orthopaedic Surgery at The First People’s Hospital of Huzhou, China. With a strong clinical and research background, he specializes in reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His expertise extends to advanced surgical techniques and the integration of innovative biomaterials to improve patient outcomes. Throughout his career, Dr. Han has collaborated with leading orthopedic researchers, contributing to high-impact studies on 3D-printed biomaterials, recombinant human parathyroid hormone biocomposites, and bone marrow aspirate concentrate therapy. His work has been published in prestigious international journals, reinforcing his role as a key contributor to orthopedic advancements. In addition to his clinical responsibilities, he is actively involved in research projects that aim to enhance musculoskeletal treatment strategies. Dr. Han’s dedication to both patient care and scientific innovation makes him a distinguished figure in the field of orthopedic surgery.

Research Interest

Dr. Jian Han’s research interests lie in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation, with a particular focus on reverse total shoulder arthroplasty, bone-to-tendon healing, and regenerative medicine. His work explores advanced surgical techniques and novel therapeutic approaches to enhance patient outcomes. He has extensively studied 3D-printed biomaterials, bioactive scaffolds, and recombinant human parathyroid hormone biocomposites, contributing to the development of innovative solutions for tendon and bone regeneration. Dr. Han is also interested in extracorporeal shockwave therapy, bone marrow aspirate concentrate therapy, and their impact on musculoskeletal healing. His research integrates biomechanics, tissue engineering, and molecular biology to advance orthopedic treatment strategies. By collaborating with leading experts in the field, he continuously explores new frontiers in orthopedic implants, prosthetic development, and minimally invasive surgical techniques. Dr. Han’s research aims to bridge the gap between clinical practice and scientific innovation, improving the effectiveness and longevity of orthopedic procedures.

Award and Honor

Dr. Jian Han has received several awards and honors in recognition of his contributions to orthopedic surgery and musculoskeletal research. His groundbreaking work in reverse total shoulder arthroplasty, bone-to-tendon healing, and biomaterials innovation has earned him accolades from prestigious medical and research institutions. He has been recognized for his high-impact publications in leading international journals, reflecting his dedication to advancing orthopedic medicine. Dr. Han has also received honors for his contributions to biomechanical research, regenerative medicine, and innovative surgical techniques, which have significantly improved patient outcomes. His collaborative studies with global experts have further solidified his reputation as a leading researcher in orthopedic surgery. In addition to his research achievements, he has been invited as a reviewer and speaker at international conferences, where he shares his expertise with the medical community. Dr. Han’s commitment to scientific excellence and innovation continues to earn him professional recognition and respect.

Research Skill

Dr. Jian Han possesses exceptional research skills in orthopedic surgery, musculoskeletal regeneration, and biomaterials innovation. His expertise includes advanced imaging techniques, biomechanical analysis, and molecular biology applications to study bone-to-tendon healing and joint reconstruction. He is proficient in 3D printing technology for biomedical applications, tissue engineering, and the development of bioactive scaffolds to enhance orthopedic treatments. Dr. Han has strong analytical and problem-solving abilities, enabling him to design and conduct clinical and experimental studies with precision. His skills in data analysis, statistical modeling, and biomechanical simulations allow him to validate surgical techniques and therapeutic interventions. He is also experienced in systematic literature reviews, grant writing, and peer-reviewed publishing, contributing significantly to orthopedic research. His ability to collaborate with multidisciplinary teams and integrate cutting-edge technologies like regenerative medicine and nanomaterials into his studies makes him a highly skilled and innovative orthopedic researcher dedicated to advancing patient care.

Conclusion

Dr. Jian Han is a highly competitive candidate for the Best Researcher Award due to his strong publication record, innovative research in orthopedic surgery, and international contributions. To further enhance his eligibility, demonstrating leadership, securing research funding, and expanding interdisciplinary collaborations would elevate his profile even more.

Publication Top Noted

Title: Bone Marrow Aspirate Concentrate Combined With an Appropriate Carrier Effectively Promotes Bone-Tendon Interface Healing in a Rabbit Model of Chronic Rotator Cuff Tear

Authors: Shengchen Han, Jian Han, Young-Kyu Kim, Hyeon Jang Jeong, Joo-Han Oh

Year: 2025

E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Geriatrician at OHSU, United States

Dr. E. Foy White-Chu, MD, CWSP, AGSF, is a distinguished geriatrician and wound care specialist at the VA Portland Health Care System (VAPHCS), where she serves as the Geriatric Fellowship Director and Wound Medical Director. She holds an Associate Professorship at Oregon Health & Science University and has extensive experience in geriatrics, wound care, and medical education. Dr. White-Chu has contributed significantly to the field through research, policy initiatives, and curriculum development, securing multiple grants for interdisciplinary wound care education. She has held leadership roles in professional organizations, including the Wound Healing Society and the American Geriatrics Society, and has served on national advisory committees. Her research, focusing on chronic wound care and skin failure in older adults, has been widely published in leading medical journals. Recognized with numerous awards, including Portland’s Top Doctors, she continues to shape healthcare practices through innovation, education, and evidence-based clinical advancements.

Professional Profile 

Education

Dr. E. Foy White-Chu earned her Doctor of Medicine (MD) degree from Baylor College of Medicine, where she developed a strong foundation in geriatric medicine and wound care. She then pursued a residency in Internal Medicine at the University of Texas Southwestern Medical Center, refining her clinical expertise in managing complex medical conditions. Driven by her passion for elderly care, she completed a Geriatrics Fellowship at the University of Texas Health Science Center at San Antonio, gaining specialized training in aging-related health issues, chronic wound care, and interdisciplinary care models. Throughout her education, Dr. White-Chu demonstrated a commitment to academic excellence, research, and medical education, laying the groundwork for her leadership in geriatric medicine. Her advanced training has enabled her to integrate evidence-based practices into clinical care, education, and policy development, contributing significantly to improving healthcare outcomes for older adults, particularly in chronic wound management and skin integrity preservation.

Professional Experience

Dr. E. Foy White-Chu is a distinguished geriatrician with extensive experience in clinical care, research, and medical education. She has held key positions in academic and healthcare institutions, specializing in geriatrics, wound care, and dermatological conditions in older adults. As an attending physician, she has provided expert care for elderly patients, focusing on chronic wound management and skin integrity. Her leadership roles have included faculty appointments where she has mentored medical students, residents, and fellows in geriatric medicine. Dr. White-Chu has contributed significantly to advancing wound care practices, integrating evidence-based approaches into clinical protocols. She has also been actively involved in research, publishing studies on pressure ulcers, dermatological health in aging populations, and best practices for geriatric care. Her dedication extends to policy advocacy, where she works to enhance healthcare standards for older adults. Through her expertise, she continues to shape the future of geriatric medicine and wound care.

Research Interest

Dr. E. Foy White-Chu’s research interests center on geriatrics, dermatology in aging populations, and wound care management. She is particularly focused on pressure ulcers, chronic wound healing, and skin integrity in elderly patients. Her work explores innovative approaches to preventing and treating wounds, emphasizing evidence-based interventions to improve patient outcomes. Dr. White-Chu also investigates the intersection of dermatological health and aging, studying conditions such as xerosis, pruritus, and other skin disorders prevalent in older adults. Additionally, she is committed to advancing geriatric care through research on best practices in long-term care settings, addressing quality-of-life concerns and improving healthcare protocols for aging populations. Her studies contribute to policy development and clinical guidelines, ensuring that older adults receive optimal care. Through her research, she continues to influence advancements in geriatric dermatology and wound management, bridging the gap between medical science and practical healthcare applications for the elderly.

Award and Honor

Dr. E. Foy White-Chu has received numerous awards and honors in recognition of her contributions to geriatrics, dermatology, and wound care management. Her dedication to improving skin integrity in aging populations has earned her accolades from professional medical associations and research institutions. She has been recognized for her excellence in clinical practice, innovative research, and leadership in geriatric healthcare. Dr. White-Chu has received distinguished service awards for her efforts in advancing wound care treatment and pressure ulcer prevention. Additionally, she has been honored for her contributions to medical education, mentoring future healthcare professionals, and enhancing best practices in long-term care settings. Her work has also been acknowledged through invitations to speak at national and international conferences, where she shares her expertise on geriatric dermatology and wound management. Through these honors, Dr. White-Chu’s impact on aging healthcare continues to be recognized and celebrated within the medical community.

Research Skill

Dr. E. Foy White-Chu possesses exceptional research skills, particularly in the fields of geriatrics, dermatology, and wound care. Her expertise lies in conducting clinical studies focused on skin integrity, pressure ulcer prevention, and advanced wound healing techniques in elderly patients. She has a strong background in designing and implementing evidence-based research methodologies, analyzing clinical data, and translating findings into practical healthcare solutions. Dr. White-Chu is skilled in interdisciplinary collaboration, working closely with healthcare professionals, researchers, and policymakers to enhance patient outcomes. Her ability to critically evaluate medical literature and contribute to peer-reviewed publications demonstrates her analytical and scientific writing proficiency. Additionally, she has experience in securing research funding, developing grant proposals, and leading innovative projects in aging-related skin care. Through her rigorous research approach, she continues to advance the understanding of geriatric dermatology, improving the quality of life for elderly individuals with chronic skin conditions.

Conclusion

Dr. E. Foy White-Chu is a highly accomplished researcher in geriatric medicine and wound care, with a strong academic, clinical, and research background. She is well-qualified for the Best Researcher Award, particularly in the domain of geriatric healthcare and wound management. Strengthening international collaborations, expanding research scope to include emerging technologies, and securing larger research grants could further enhance her competitiveness for this prestigious recognition.

Publications Top Noted

Title: Healing a Gap in Medical Education: Efficacy of a Wound Care Didactic Intervention
Authors: Sarah L. Becker, Elizabeth Foy White-Chu, Elena Paz Munoz, Martha A. Oberg, Alex Gerardo Ortega-Loayza
Year: 2025
Citations: 0

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O

Johann Christian | Health Professions | Best Researcher Award

Published on by Global Scholar Awards

Dr. Johann Christian | Health Professions | Best Researcher Award

Emergency Physician at Sittmann University of Cape Town, South Africa

Dr. Johann Christian Sittmann, a Specialist Emergency Physician from South Africa, exemplifies excellence in clinical care, research, and education. With an MBChB from Stellenbosch University and an MMed in Emergency Medicine from the University of Cape Town, he is certified in advanced life support, disaster management, and emergency ultrasound. Dr. Sittmann’s expertise spans trauma, pediatric emergency care, and critical care, with a passion for improving healthcare quality in resource-limited settings. A dedicated educator, he has trained medical students and registrars in life support, ventilation strategies, and toxicology. His research contributions include an award-winning presentation on emergency thoracotomies, showcasing his commitment to advancing medical knowledge. As a facilitator in disaster medicine and point-of-care ultrasound, Dr. Sittmann demonstrates leadership in systems development. With a focus on impactful and socially responsible medicine, he is an exceptional candidate for recognition as a Best Researcher Award recipient.

Professional Profile 

Education

Dr. Johann Christian Sittmann has a robust academic foundation that underpins his expertise in emergency medicine. He earned his MBChB degree from Stellenbosch University, laying the groundwork for his medical career. Committed to advancing his knowledge and skills, he pursued a Master of Medicine (MMed) in Emergency Medicine at the University of Cape Town, which he completed in 2023. Dr. Sittmann has also obtained numerous specialized certifications, including Basic Surgical Skills, Advanced Cardiovascular Life Support (ACLS), Pediatric Advanced Life Support (PALS), and the Advanced Trauma Life Support (ATLS) course. His qualifications extend to critical areas such as aeromedical transfer medicine, disaster management, and point-of-care ultrasound, ensuring a comprehensive skill set in emergency medicine. Additionally, his certification in “Understanding Clinical Research: Behind the Statistics” reflects his dedication to evidence-based practice and research. Dr. Sittmann’s education equips him with the knowledge and expertise to excel in clinical and academic settings.

Professional Experience

Dr. Johann Christian Sittmann brings extensive professional experience as a Specialist Emergency Physician, combining clinical excellence with a passion for education and systems development. His medical journey includes serving as an Emergency Medicine Registrar from 2020 to 2023 in Cape Town, where he honed his expertise in trauma, pediatric emergency care, and critical care. Dr. Sittmann is a dedicated educator, having trained undergraduate and postgraduate students in life support techniques, ventilation strategies, toxicology, and emergency medical protocols. His leadership extends to disaster management, where he has facilitated major incident medical management courses and disaster medicine programs. A strong advocate for advancing medical knowledge, he has conducted impactful research, including an award-winning presentation on thoracotomies in district hospitals. With a focus on resource-limited settings, Dr. Sittmann’s professional experience reflects his commitment to improving healthcare quality, fostering innovation, and inspiring future medical professionals through his clinical and academic contributions.

Research Interest

Dr. Johann Christian Sittmann’s research interests center on advancing emergency medicine, with a particular focus on trauma, pediatric emergency care, critical care, and healthcare quality improvement in resource-limited settings. He is passionate about exploring innovative approaches to enhance patient outcomes in emergency scenarios, especially in environments with constrained resources. His work includes studying the indications, procedures, and outcomes of emergency thoracotomies, a topic he presented in an award-winning research presentation. Dr. Sittmann is also dedicated to disaster medicine, investigating effective strategies for managing major incidents and improving disaster response systems. Additionally, he has a keen interest in leveraging point-of-care ultrasound to enhance diagnostic accuracy in emergency care. By combining clinical expertise with evidence-based research, Dr. Sittmann aims to contribute to the development of effective, scalable solutions that address global healthcare challenges, particularly in underserved regions, while advancing knowledge in the field of emergency medicine.

Award and Honor

Dr. Johann Christian Sittmann has been recognized for his exceptional contributions to emergency medicine through awards and honors that highlight his dedication to clinical excellence and research. Notably, he received the Best Oral Presentation Award at the UCT FaCE Research Day in 2023 for his study titled “Emergency Centre Thoracotomies in a District Hospital Complex in the Western Cape: A Descriptive Analysis of Indications, Procedure, and Outcomes.” This accolade underscores his ability to conduct impactful research with practical implications for emergency care. Beyond research, Dr. Sittmann has earned respect as a leader and educator, contributing to disaster medicine and emergency point-of-care ultrasound training programs. His numerous certifications, including advanced life support and disaster management, further attest to his commitment to professional growth and excellence. These achievements reflect Dr. Sittmann’s relentless pursuit of innovation and quality improvement in emergency medicine, earning him distinction in his field.

Conclusion

Dr. Johann Christian Sittmann is a highly qualified candidate for the Best Researcher Award, particularly in fields related to emergency medicine, disaster management, and education. His combination of clinical expertise, research acumen, and commitment to improving healthcare in resource-limited settings makes him a strong contender. Strengthening his profile with more peer-reviewed publications and measurable impact data could further solidify his case for recognition.

Publications Top Noted

Title: Emergency Centre Thoracotomy for Penetrating Trauma: Insights from 2 South African District-level Emergency Centres
Authors: Johann Christian Sittmann, Ferhana Gool, Katya Evans
Year: 2024
Citation (APA Style):
Sittmann, J. C., Gool, F., & Evans, K. (2024). Emergency Centre Thoracotomy for Penetrating Trauma: Insights from 2 South African District-level Emergency Centres. Injury. Available online 21 December 2024.

Jean-Christophe Rwigema | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Jean-Christophe Rwigema | Medicine and Dentistry | Best Researcher Award

Resident Physician at Endeavor Health, United States

Jean-Christophe N. Rwigema, MD, MPH, is a dedicated medical professional specializing in surgery, with a focus on foregut and bariatric surgery. He is currently a postdoctoral research fellow at NorthShore University Health System, where he engages in clinical research to advance surgical practices and improve patient outcomes. Dr. Rwigema earned his Doctor of Medicine and Master of Public Health from the Keck School of Medicine of USC, equipping him with a comprehensive understanding of both clinical medicine and public health challenges. His commitment to improving community health is evident in his involvement in various health initiatives, and he continues to shape the next generation of healthcare professionals through mentoring and leadership roles in medical education.

Professional Profile

Education

Dr. Rwigema received his medical degree from the Keck School of Medicine of the University of Southern California, where he also completed a Master of Public Health. His academic journey began at the University of California, Irvine, where he earned a Bachelor of Science in Biological Sciences. He further pursued postbaccalaureate training at the University of California, San Diego, in their School of Medicine. Currently, he is completing his residency in General Surgery at the University of Florida College of Medicine Jacksonville, anticipating graduation in June 2027. This diverse educational background, combining rigorous medical training with public health expertise, provides Dr. Rwigema with a unique perspective on patient care and healthcare systems.

Professional Experience

Dr. Rwigema’s professional experience encompasses various roles in clinical research and surgical practice. As a Surgical Research Fellow at NorthShore University Health System, he actively participates in clinical trials focused on foregut and bariatric surgery. He previously worked as a Medical Student Researcher at the Keck School of Medicine, where he assessed disparities in lung cancer incidence and the impact of electronic medical records on patient interactions. His leadership roles, including co-organizing the Firearm Violence Prevention Symposium and mentoring aspiring healthcare professionals, showcase his commitment to community health and education. These experiences highlight his strong foundation in both clinical practice and research, positioning him as a leader in the medical field.

Research Interests

Dr. Rwigema’s research interests lie at the intersection of surgical innovation and public health. His current focus on foregut and bariatric surgery aims to improve patient outcomes through evidence-based practices. He has contributed to several studies assessing esophageal motility disorders and evaluating the effectiveness of surgical interventions such as Toupet fundoplication. Additionally, his interest in health disparities, particularly among gender minority individuals, reflects his commitment to addressing inequities in healthcare access and treatment. Through his research, Dr. Rwigema aims to advance surgical methodologies and enhance the quality of care for diverse patient populations.

Awards and Honors

Dr. Rwigema has received recognition for his contributions to medical research and community health initiatives. His work has led to multiple peer-reviewed publications, with articles published in notable surgical journals. He has presented his research at prestigious conferences, including the Central Surgical Association and SAGES Annual Meeting, further establishing his reputation in the surgical community. His leadership and mentorship roles, such as coordinating events for the Student National Medical Association, demonstrate his commitment to promoting diversity in medicine. As he continues his journey in the medical field, Dr. Rwigema is poised to achieve further accolades and make significant contributions to surgical research and public health.

Conclusion

Dr. Jean-Christophe N. Rwigema is a highly qualified candidate for the Best Researcher Award due to his extensive and ongoing research in surgery, particularly foregut and bariatric surgery, with numerous publications and presentations that highlight his contributions. While he has demonstrated strong collaborative research and leadership skills, his profile could be further strengthened by more independent, focused research leadership and a clearer specialization. Overall, his academic and professional accomplishments, coupled with his promising career trajectory, make him a competitive candidate for the award.

Publication top noted

  • Using Impedance Planimetry (EndoFLIP) to Determine Ideal Distensibility Ranges for Esophageal Motility Disorders
    📄 Rwigema, J.-C.N., Kuchta, K., Anderson, D.J., … Hedberg, H.M., Ujiki, M.B.
    🗓️ 2024
    🔗 Surgery (United States), in press
  • Impact of Toupet Fundoplication with Bougie on Post-Operative Dysphagia and Quality of Life
    📄 Anderson, D.J., Kuchta, K., Joseph, S., … Hedberg, H.M., Ujiki, M.B., Rwigema, J.-C.N.
    🗓️ 2024
    🔗 Surgical Endoscopy, 38(9), pp. 5350–5355
  • Efficacy and Outcomes of Per Oral Plication of the (Neo)esophagus (POPE) for Impaired Emptying in Achalasia and Post-Esophagectomy Patients
    📄 Crafts, T.D., Seidel, H., Hedberg, H.M., … Ishii, S., Ujiki, M.B.
    🗓️ 2024
    🔗 Surgical Endoscopy, 38(9), pp. 5239–5245
  • Assessing Disparities in Lung Cancer Incidence for Gender Minority Individuals Using California Cancer Registry Data
    📄 Liu, L., Rwigema, J.-C.N., Song, Z., … Kim, S.E., David, E.A.
    🗓️ 2021
    🔗 Chest, 159(6), pp. 2491–2493